A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(11 sites)

United States

Cedars-Sinai Medical Center, Los Angeles, California

Stanford University (Data Collection Only), Stanford, California

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey

Hackensack Meridian Health (Data Collection Only), Hackensack, New Jersey

Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York

Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York

MD Anderson Cancer Center (Data Collection Only), Houston, Texas